After dosing mix-up, latest COVID-19 vaccine success comes with big question mark
Researchers wonder why lower dose prompted better efficacy in study of vaccine candidate from the University of Oxford and AstraZeneca
Related Articles
A university cut tenured faculty’s pay. They’re suing
“It’s created significant financial hardship,” one plaintiff in the Tufts University case says
U.K. visa changes imperil recruitment of scientific talent, policy experts warn
Skyrocketing visa costs and new restrictions make it harder to attract talent and students, threatening universities’ bottom lines
‘I need your urine!’ Unusual experiment tests whether human pee can help save forests
Science chats with a Spanish ecologist who tried a surprising tactic to stop mice from eating acorns
Hiring ban disrupts research at Florida universities
Suit seeks to overturn state law targeting graduate and postdocs from China and other “countries of concern”
Amid budget crunch, NASA seeks Hail Mary on Mars Sample Return
U.S. space agency calls for new proposals to reduce mission’s cost
News at a glance: Global coral bleaching, preventing ship strikes on whales, and detecting prostate cancer
The latest in science and policy
Traffic noise causes lifelong harm to baby birds
Finches exposed to the sound of cars grew slower and had fewer offspring
A gene mutation turned these fish into intrepid explorers
That behavioral change could explain the remarkable diversity of cichlid fish in Africa’s Lake Tanganyika
Microbe stops mosquitoes from harboring malaria parasite
Strategy could provide additional weapon against spread of deadly disease